Also in this section

• News Home
• News Archive
• Patients at high risk of a heart attack or stroke are under treated
• A 360 degree view of healthcare innovation
• Back care doesn't measure up
• New research: time for Australia to target salt
• New recommendations to enhance registration processes of drugs for neglected diseases in Africa
• Chinese delegation visit to The George
• Salt Targets for Packaged and Restaurant Foods
• New Australian research highlights gaps in treating cardiovascular risks
• The polypill: addressing cardiovascular risk in Indigenous Australians
• Food policy for good health, learning from the UK
• Coffee and tea protects against diabetes
• US$3billion spent on neglected disease R&D in 2008
• Call for high salt warning on Angry Beef Burger
• Self harm: major road safety issue for young drivers
• New China research Center to address threat of chronic disease
• New research center to address threat of chronic disease in China
• Research reveals uncertainty around effectiveness of common treatment used in high-risk kidney patients.
• Introducing the Young Driver Factbase
• Providing essential information for physiotherapists
• Staff profile: Professor Lijing Yan - The George Institute, China
• Mild traumatic brain injury high among non-professional rugby players
• Research findings confirm aggressive kidney treatments not justified
• Mandawuy Yunupingu discusses his battle with chronic kidney disease
• Is paracetamol effective for back pain?
• Major health initiatives receive funding from Australia's National Health and Medical Research Council
• Four out of 10 chronic back pain sufferers will recover within a year
• Association found between school safety program and reduced risk of crash
• Back Pain Unlikely Symptom Of Serious Disease
• Rural Roads Dangerous For Young Drivers
• Many Australians At Risk Of Cardiovascular Disease Are Not Receiving Best Practice Care
• New analysis confirms benefits for type 2 diabetes

Staff profile: Professor Lijing Yan - The George Institute, China

Professor Lijing L. Yan
Director, Research and Development
The George Institute, China

A cardiovascular epidemiologist with a background in demography and health economics, Professor Lijing Yan, is the Director of Research and Development at The George Institute, China.

After receiving her Bachelor’s degree in Sociology from Peking University, Lijing secured her Masters of Public Health in Epidemiology and doctoral degree in Demography from the University of California, Berkeley. Before joining The George Institute, Lijing spent some time in the USA working for the National Bureau of Economic Research (Stanford, California), the Department of Preventive Medicine, Feinberg School of Medicine, Northwestern University (Chicago, IL), and most recently in China at the Department of Health Economics and Management, Guanghua School of Management, Peking University.

Lijing has authored a significant number papers in peer-reviewed journals and says a career highlight has been her several publications in the Journal of the American Medical Association.

Her main research interests include chronic disease prevention and control, economic evaluations in health care, and integrated health management. Lijing is also Director the first Center for Chronic Disease Prevention in China, which will be hosted at The George Institute, China and play a vital role in producing evidence that will lead to substantial, positive health and policy outcomes. The centre will conduct research that will provide reliable new evidence to inform the best strategies for the prevention and treatment of cardiovascular diseases.

Lijing is also an adjunct Associate Professor at the Department of Preventive Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA and the Health Economics and Management Institute, Guanghua School of Management, Peking University, Beijing, China.